Aziyo Biologics Inc investor relations material

Aziyo Biologics, Inc. (Aziyo) is a regenerative medicine company focused on the development of biologic products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. The Company has several products in development utilizing its patented Biowrap platform, which provides a biocompatible scaffold upon which cells can proliferate in three dimensions and then migrate into desired sites to form new tissue structures. Aziyo’s product candidates include products based on human mesenchymal stem cells (MSCs), platelet-rich plasma (PRP), and autologous platelet gel derived from platelet rich plasma (PG-PRP) for cardiovascular indications; its MSCs for orthopedic and spinal procedures; as well as its PRP for soft tissue augmentation applications.